Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Atherosclerotic Plaque Calcium Characterization for Predicting Ruptured Plaques

NCT03849521 is registered in ClinicalTrials.gov with Li Min as lead sponsor.

NCT NCT03849521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03849521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Atherosclerotic Plaque Calcium Characterization for Predicting Ruptured Plaques
Lead sponsor
Li Min
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2019
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulnerable atherosclerotic plaque